Syracuse, New York, United States MedTech appeared to be the Corporate Investor, which was created in 2004. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Syracuse.
The usual cause for the fund is to invest in rounds with 1 partaker.
Among the most popular portfolio startups of the fund, we may highlight Isotopen Technologien Mu00fcnchen, Isotopen Technologien Mu00fcnchen. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany. The fund has specific favorite in a number of founders of portfolio startups.
The higher amount of exits for fund were in 2009. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. The usual things for fund are deals in the range of 10 - 50 millions dollars.
| Fund Name | Location |
| 7RIDGE | - |
| AZ Digital Farm | Arizona, Scottsdale, United States |
| Buckley Endeavors | - |
| Canadian Glycomics Network | - |
| Chenavari Investment Managers | England, London, United Kingdom |
| Conegliano Venture | New York, New York, United States |
| InteBridge | China, Guangdong, Shenzhen |
| Plainfield Asset Management LLC | Connecticut, Greenwich, United States |
| Talisman Capital | Columbus, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 